Paediatric Drug Development 2011

Key Speakers • Samuel Maldonado, Vice-President and Head of Paediatric Drug Development 2011, Johnson & Johnson • David McIntosh, Global Scientific Affairs Senior Expert, Novartis • Hans-Leonhard Ohrem, Technical Manager, Merck • Deborah Bickmann, Boehringer Ingelheim • Jacek Bedkowski, Senior Regulatory Affairs Associate, Baxter • Sarah Branch, Special Populations Group Manager, MHRA • Klaus Rose, Principal Consultant, Granzer Regulatory Consulting & Services (Former Head of Paediatrics, Roche) • Philippa Smit-Marshall, Vice President, Medical Affairs, Pharmanet Consultancy • Ian Friedland, Study Director, Cubist Pharmaceuticals • Timo Vesikari, Professor of Virology and Consultant Paediatrician, University of Tampere • Daniel Bar-Shalom, Associate Professor, University of Copenhagen • Steffen Gay, Department of Rheumatology, University Hospital Zürich

Visitors profile
Senior VPs, Chief Scientific Officers, Directors, Managers, Professors, Scientists, and Principal Investigators in: • Paediatric Medicine • Research & Development • Clinical Trials • Therapeutics • Drug Delivery • Drug Discovery • Formulation Devel